The combination of transcatheter arterial chemoembolisation and thermal ablation versus TACE alone for hepatocellular carcinoma
The combination of transcatheter arterial chemoembolisation and thermal ablation versus TACE alone for hepatocellular carcinoma Background Hepatocellular carcinoma (a common kind of liver cancer) is the sixth most common cancer in the world. Transcatheter arterial chemoembolisation (TACE) (injecting agents into the feeding vessels of the tumour to reduce the blood supply to the tumour and kill the tumour) is the most common therapy for hepatocellular carcinoma, but the clinical outcome is poor. In recent years, the combination of TACE plus thermal ablation (killing the tumour cell by...